CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

September 27, 2024 · earnings

ESLA earnings: a positive outcome, +22.7%

On September 27, 2024, Estrella Immunopharma, Inc. reached its earnings. The result was a positive outcome, and the stock moved +22.7% in the window around the event. It had already run -22.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$0.97
1d before
$1.19
Event day
$1.19
1d after
$1.24
5d after

Pre-catalyst setup

-22.9%
30-day run-up
13206%
30-day volatility
0.2×
volume spike